1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Cisplatin versus carboplatin: comparative review of therapeutic management in solid malignancies.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The platinum analogues, cisplatin and carboplatin, are among the most widely used chemotherapeutic agents in oncology. Both agents have a broad spectrum of clinical activity in numerous malignancies including gynaecological cancers, germ cell tumours, head and neck cancer, thoracic cancers and bladder cancer. Although the final mechanism of inducing tumour cell apoptosis is similar for both compounds, cisplatin has been shown to be more effective in treating specific tumour types. Whilst more favourable toxicity profiles are often associated with carboplatin, this can frequently translate to inferior response in certain malignancies. This review succinctly collates the evidence for the preferential use of these platinum analogues in particular settings in addition to the long-standing dilemma surrounding the paucity of biomarkers predicting response to these agents.

          Related collections

          Author and article information

          Journal
          Crit. Rev. Oncol. Hematol.
          Critical reviews in oncology/hematology
          Elsevier BV
          1879-0461
          1040-8428
          Jun 2016
          : 102
          Affiliations
          [1 ] School of Medicine, University of Queensland, QLD 4072, Australia; Mater Health Services, Raymond Terrace, South Brisbane, QLD 4101, Australia; Walter & Eliza Hall Institute, 1G Royal Parade, Parkville, VIC 3052, Australia.
          [2 ] Mater Health Services, Raymond Terrace, South Brisbane, QLD 4101, Australia.
          [3 ] School of Medicine, University of Queensland, QLD 4072, Australia; Mater Health Services, Raymond Terrace, South Brisbane, QLD 4101, Australia; Princess Alexandra Hospital, Ipswich Road, Woolloongabba, QLD 4102, Australia. Electronic address: Jermaine.Coward@health.qld.gov.au.
          Article
          S1040-8428(16)30055-5
          10.1016/j.critrevonc.2016.03.014
          27105947

          Comments

          Comment on this article